Merck KGaA Sees Earnings, Sales at Lower Half of Outlook Ranges

Germany’s Merck KGaA expects earnings and sales for 2023 to be at the lower half of its outlook ranges, after reporting lower third-quarter revenue across all segments.

The life-sciences and chemical group said Thursday that it now expects net sales trending slightly below the mid-point of its range of 20.5 billion euros to 21.9 billion euros ($21.96 billion-$23.46 billion). Meanwhile, earnings before interest, taxes, depreciation and amortization excluding one-time items are forecast to come in at the lower half of its EUR5.8 billion to EUR6.4 billion range.